Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
Frontiers in Oncology|July 26, 2021
Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry ExperienceAnna Crispo, Maria Teresa Corradin, Erika Giulioni, et al.
The Journal of Dermatological Treatment|October 10, 2024
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis)Luigi Gargiulo, Luciano Ibba, Angela Alfano, et al.
International Journal of Dermatology|September 30, 2025
Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK InhibitorsMiguel Antonio Lasheras-Pérez, María Concepción Garrido-Ruiz, Alejandro Lobato-Berezo, et al.
Plos One|August 14, 2020
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasisEmanuele Scala, Matteo Megna, Paolo Amerio, et al.
International Journal of Dermatology|May 24, 2022
Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approachClara De Simone, Paolo Dapavo, Piergiorgio Malagoli, et al.
Dermatology and Therapy|July 24, 2025
JAK Inhibitors in Atopic Dermatitis: Does Weight Matter? A Real-World, Nationwide Retrospective Study: IL-AD (Italian Landscape Atopic Dermatitis)Mariateresa Rossi, Stefano Bighetti, Alessandra Narcisi, et al.
Cancer Medicine|June 20, 2019
Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational studyAntonio Tejera-Vaquerizo, Simone Ribero, Susana Puig, et al.
Dermatology and Therapy|May 29, 2026
Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)Luca Potestio, Cataldo Patruno, Silvia Mariel Ferrucci, et al.
Dermatology and Therapy|April 23, 2025
Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg-IL PSO (Italian Landscape Psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Journal of Clinical Medicine|December 24, 2021
Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching StudyAntonio Tejera-Vaquerizo, Aram Boada, Simone Ribero, et al.
Pageof 27